|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/14 | (2006.01) |
| A61K 9/00 | (2006.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 9/32 | (2006.01) | ||
| A61K 9/36 | (2006.01) | ||
| A61K 31/167 | (2006.01) | ||
| A61K 31/277 | (2006.01) | ||
| A61K 47/32 | (2006.01) | ||
| A61K 47/38 | (2006.01) | ||
| A61P 5/28 | (2006.01) | ||
| A61P 13/08 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1368001 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02712105.2 |
| Date of filing the European patent application | 2002-02-22 | |
| (97) | Date of publication of the European application | 2003-12-10 |
| (45) | Date of publication and mention of the grant of the patent | 2005-10-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2002/000766 |
| Date | 2002-02-22 |
| (87) | Number | WO 2002/067893 |
| Date | 2002-09-06 |
| (30) | Number | Date | Country code |
| 0104749 | 2001-02-27 | GB | |
| 0102572 | 2001-07-19 | SE |
| (72) |
BATEMAN, Nicola, GB
CAHILL, Julie, GB
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (54) | PHARMACEUTICAL FORMULATION COMPRISING BICALUTAMIDE |
| PHARMACEUTICAL FORMULATION COMPRISING BICALUTAMIDE |